Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
The Clinical Technologist II – Certified (Quality) is an integral member of the Clinical Laboratory Team. The role is supporting management of the SCCA POCT Program.
The Quality Technologist (QT) will be responsible for POCT and associated Quality Processes under the direction of the QA Manager, Clinical Labs. The program provides oversight of all testing performed at the points of patient care throughout the SCCA Clinic. The program is overseen and run by the Lab Quality Department. Testing includes all testing completed at the bed side during patient care. Testing personnel include nurses, physicians, MAs and other clinical care providers.
Clinical Laboratory Quality
Education and Certification:
SCCA has a mandatory COVID-19 vaccination policy, and there are no exceptions for any employee who is patient-facing and/or requires access to SCCA facilities.
Exceptions exist only for employees whose positions are fully remote, with no required access to campus. As a condition of employment, newly hired employees requiring access to campus must provide proof of vaccination before their first day of employment.